These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22725717)

  • 41. [Clinical and pathological analysis on aristolochi acid induced chronic renal impairement in 16 patients].
    Ma YL; Tang ZY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Nov; 24(11):1046. PubMed ID: 15609612
    [No Abstract]   [Full Text] [Related]  

  • 42. [Query on the cause of "belgium nephropathy" (Chinese herb nephropathy) and the speculation on carcinogenesis of Chinese herbs].
    Li YM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Feb; 22(2):142-5. PubMed ID: 12585157
    [No Abstract]   [Full Text] [Related]  

  • 43. Chinese herbal uropathy and nephropathy.
    Laing C; Hamour S; Sheaff M; Miller R; Woolfson R
    Lancet; 2006 Jul; 368(9532):338. PubMed ID: 16860704
    [No Abstract]   [Full Text] [Related]  

  • 44. Update of aristolochic acid nephropathy in Korea.
    Ban TH; Min JW; Seo C; Kim DR; Lee YH; Chung BH; Jeong KH; Lee JW; Kim BS; Lee SH; Choi BS; Han JS; Yang CW
    Korean J Intern Med; 2018 Sep; 33(5):961-969. PubMed ID: 29551056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is "Chinese herbs nephropathy" a prejudicial term?
    Solez K; Daugirdas J; Gregory MC; Frohnert PP; Bhowmik DM; Jha V; Cosyns JP
    Am J Kidney Dis; 2001 Nov; 38(5):1141-2. PubMed ID: 11684575
    [No Abstract]   [Full Text] [Related]  

  • 46. Re: Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Su YC; Lin JS; Lee MT; Li TC; Lee SM
    J Natl Cancer Inst; 2010 Jul; 102(13):988; author reply 988-90. PubMed ID: 20479292
    [No Abstract]   [Full Text] [Related]  

  • 47. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.
    Wang SM; Lai MN; Wei A; Chen YY; Pu YS; Chen PC; Wang JD
    PLoS One; 2014; 9(8):e105218. PubMed ID: 25170766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid.
    Lai MN; Lai JN; Chen PC; Tseng WL; Chen YY; Hwang JS; Wang JD
    Nephrology (Carlton); 2009 Apr; 14(2):227-34. PubMed ID: 19076288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy.
    Kazama I; Matsubara M; Michimata M; Suzuki M; Hatano R; Sato H; Ito S
    Clin Exp Nephrol; 2004 Sep; 8(3):283-7. PubMed ID: 15480910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluating the complexities of the development of botanical medicine].
    Zhang JC; Chen KJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 May; 23(5):324-6. PubMed ID: 12800409
    [No Abstract]   [Full Text] [Related]  

  • 51. Reversible Fanconi syndrome after ingestion of a Chinese herbal 'remedy' containing aristolochic acid.
    Krumme B; Endmeir R; Vanhaelen M; Walb D
    Nephrol Dial Transplant; 2001 Feb; 16(2):400-2. PubMed ID: 11158421
    [No Abstract]   [Full Text] [Related]  

  • 52. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Lai MN; Wang SM; Chen PC; Chen YY; Wang JD
    J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nephropathy caused by Chinese plants and aristolochic acids: from clinical observation to experimental model].
    Debelle F; Nortier J
    Bull Mem Acad R Med Belg; 2006; 161(5):327-33. PubMed ID: 17283906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Renal failure after eczema treatment with Chinese herbal medicine].
    Hautarzt; 2000 Apr; 51(4):297. PubMed ID: 10810668
    [No Abstract]   [Full Text] [Related]  

  • 55. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
    Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
    Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A comparative study of manchurian Dutchmanspipe and antibiotics induced acute tubular necrosis in renal cellular biological features].
    Yang L; Li XM; Wang HY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 May; 23(5):329-34. PubMed ID: 12800411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drugs and AKI.
    Liangos O
    Minerva Urol Nefrol; 2012 Mar; 64(1):51-62. PubMed ID: 22402317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome.
    Schetter AJ; Harris CC
    Proc Natl Acad Sci U S A; 2012 May; 109(21):7955-6. PubMed ID: 22592801
    [No Abstract]   [Full Text] [Related]  

  • 59. Editorial comment.
    Landrigan PJ
    J Urol; 2013 Jan; 189(1):52. PubMed ID: 23164374
    [No Abstract]   [Full Text] [Related]  

  • 60. Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer.
    Zlotta AR; Roumeguere T; Kuk C; Alkhateeb S; Rorive S; Lemy A; van der Kwast TH; Fleshner NE; Jewett MA; Finelli A; Schulman C; Lotan Y; Shariat SF; Nortier J
    Eur Urol; 2011 Jun; 59(6):1026-31. PubMed ID: 21458152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.